seach.co.ilCrawled Nov 22, 2026
Seach Medical Group’s medical cannabis catalog includes flowers, oils, and pre-rolls, categorized by type and strain, for licensed users only.
Seach Medical Group provides medical cannabis flowers, oils, and pre-rolls categorized by type and strain.
Seach Medical Group offers career opportunities in medical cannabis within a dynamic and challenging work environment.
The Cannabis Brothers series at Seach Medical Group introduces three new strains, detailing their genetics and categories.
Seach Medical Group, founded by a family, combines research and standards to develop medical cannabis products for patients.
Seach Medical Group, a pioneer in medical cannabis since 2008, was founded by the Sherid family after experiencing cannabis’s positive effects through their father’s illness.
Seach Medical Group collaborates with clinical researchers and academic partners on medical cannabis studies in Israel.
Seach Medical Group provides investor reports, presentations, and updates on its cultivation, production, and marketing of medical cannabis.
Seach Medical Group offers medical cannabis products tailored for inhalation or smoking, along with assistance navigating medical cannabis licensing bureaucracy.
Seach Medical Group, a family-controlled cannabis grower and pharmacy operator, posts a **NIS 9.7 million profit in H1 2026**, contrasting with financial difficulties faced by competitors. The company operates its own cultivation facilities and pharmacies, integrating vertical control over production and distribution. Profitability highlights its operational resilience in Israel’s regulated cannabis market.
Israel’s medical cannabis companies face existential challenges due to internal mismanagement and self-inflicted crises. Regulatory pressures and operational failures have eroded investor confidence and market stability. The sector struggles to sustain growth amid mounting legal and financial hurdles.
Israel’s cannabis industry integrates with Orthodox Jewish traditions by exploring **kashrut (kosher) certification** for cannabis products. The country’s advanced medical cannabis market—home to over **100,000 licensed patients**—now examines religious compliance, building on historical Jewish use of cannabis for spiritual purposes. Israeli scientists and rabbinical authorities collaborate to address production, consumption, and ritual observance in alignment with Jewish law.
A company has received the first *shemita* certification for growing and marketing medical cannabis products. This certification aligns religious dietary laws with cannabis cultivation, addressing a previously unmet demand in the industry. The milestone marks a shift in how kosher standards apply to emerging sectors like medical cannabis.
Seach Medical Group, an Israeli cannabis producer, has agreed to export two tons of medical marijuana to Australia by the end of 2022. The company has already shipped 120kg of its 'Black' and 'Kush-Dan' strains to its Australian partner, Cannatrek, which specializes in cannabis research, cultivation, and distribution. Seach’s deal supports Cannatrek’s efforts to supply medical cannabis to Australian patients.
Israel exports its first commercial medical cannabis shipment to Australia, marking a milestone in its medical cannabis trade despite regulatory delays. The move follows Israel’s 2019 approval of medical cannabis exports, though implementation faced hurdles tied to legislative reforms proposed by Knesset member Ya'acov Litzman in 2017. The shipment represents a breakthrough for Israeli cannabis producers seeking international markets.
Seach Medical Group develops medical cannabis formulations targeting conditions like autism. The company is currently conducting trials with 100 children and adolescents. Seach now aims to extend its operations into European markets.